{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:27:46Z","timestamp":1774351666148,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T00:00:00Z","timestamp":1512432000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00415-017-8668-8","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T04:56:38Z","timestamp":1512449798000},"page":"299-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Age-dependent cognitive dysfunction in untreated hereditary transthyretin amyloidosis"],"prefix":"10.1007","volume":"265","author":[{"given":"Ana","family":"Martins da Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Cavaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Sam\u00f5es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcio","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery W.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cec\u00edlia","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,5]]},"reference":[{"issue":"9","key":"8668_CR1","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/jnnp-2014-308724","volume":"86","author":"Y Sekijima","year":"2015","unstructured":"Sekijima Y (2015) Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. J Neurol Neurosurg Psychiatry 86(9):1036\u20131043","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"8668_CR2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/brain\/75.3.408","volume":"75","author":"C Andrade","year":"1952","unstructured":"Andrade C (1952) A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 75(3):408\u2013427","journal-title":"Brain"},{"issue":"2","key":"8668_CR3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10741-015-9480-0","volume":"20","author":"C Rapezzi","year":"2015","unstructured":"Rapezzi C et al (2015) Cardiac amyloidosis: the great pretender. Heart Fail Rev 20(2):117\u2013124","journal-title":"Heart Fail Rev"},{"issue":"15","key":"8668_CR4","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/WNL.0b013e3181a0fe74","volume":"72","author":"K Hagiwara","year":"2009","unstructured":"Hagiwara K et al (2009) Highly selective leptomeningeal amyloidosis with transthyretin variant Ala25Thr. Neurology 72(15):1358\u20131360","journal-title":"Neurology"},{"issue":"6","key":"8668_CR5","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1212\/WNL.47.6.1562","volume":"47","author":"F Garzuly","year":"1996","unstructured":"Garzuly F et al (1996) Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly). Neurology 47(6):1562\u20131567","journal-title":"Neurology"},{"issue":"1","key":"8668_CR6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2005.01.018","volume":"121","author":"Y Sekijima","year":"2005","unstructured":"Sekijima Y et al (2005) The biological and chemical basis for tissue-selective amyloid disease. Cell 121(1):73\u201385","journal-title":"Cell"},{"issue":"12","key":"8668_CR7","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","volume":"10","author":"V Plante-Bordeneuve","year":"2011","unstructured":"Plante-Bordeneuve V, Said G (2011) Familial amyloid polyneuropathy. Lancet Neurol 10(12):1086\u20131097","journal-title":"Lancet Neurol"},{"issue":"1\u20132","key":"8668_CR8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jns.2009.07.028","volume":"287","author":"H Koike","year":"2009","unstructured":"Koike H et al (2009) Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy. J Neurol Sci 287(1\u20132):178\u2013184","journal-title":"J Neurol Sci"},{"issue":"6","key":"8668_CR9","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ajmg.1320600606","volume":"60","author":"A Sousa","year":"1995","unstructured":"Sousa A et al (1995) Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 60(6):512\u2013521","journal-title":"Am J Med Genet"},{"issue":"3","key":"8668_CR10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/jnnp-2013-305383","volume":"85","author":"C Lemos","year":"2014","unstructured":"Lemos C et al (2014) Overcoming artefact: anticipation in 284 Portuguese kindreds with familial amyloid polyneuropathy (FAP) ATTRV30M. J Neurol Neurosurg Psychiatry 85(3):326\u2013330","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"8668_CR11","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/archneur.59.11.1771","volume":"59","author":"H Koike","year":"2002","unstructured":"Koike H et al (2002) Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form. Arch Neurol 59(11):1771\u20131776","journal-title":"Arch Neurol"},{"issue":"6","key":"8668_CR12","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/ana.24519","volume":"78","author":"LL Mariani","year":"2015","unstructured":"Mariani LL et al (2015) Genotype\u2013phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France. Ann Neurol 78(6):901\u2013916","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"8668_CR13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/13506129.2012.674580","volume":"19","author":"H Koike","year":"2012","unstructured":"Koike H, Sobue G (2012) Late-onset familial amyloid polyneuropathy in Japan. Amyloid 19(Suppl 1):55\u201357","journal-title":"Amyloid"},{"issue":"1","key":"8668_CR14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/mus.20644","volume":"35","author":"I Conceicao","year":"2007","unstructured":"Conceicao I, De Carvalho M (2007) Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal. Muscle Nerve 35(1):116\u2013118","journal-title":"Muscle Nerve"},{"issue":"Pt 10","key":"8668_CR15","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/brain\/122.10.1951","volume":"122","author":"K Misu","year":"1999","unstructured":"Misu K et al (1999) Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Brain 122(Pt 10):1951\u20131962","journal-title":"Brain"},{"issue":"1","key":"8668_CR16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2013.10.033","volume":"170","author":"M Tasaki","year":"2013","unstructured":"Tasaki M et al (2013) Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: a proteomic approach. Int J Cardiol 170(1):69\u201374","journal-title":"Int J Cardiol"},{"issue":"5","key":"8668_CR17","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/BF00310133","volume":"81","author":"M Ushiyama","year":"1991","unstructured":"Ushiyama M, Ikeda S, Yanagisawa N (1991) Transthyretin-type cerebral amyloid angiopathy in type I familial amyloid polyneuropathy. Acta Neuropathol 81(5):524\u2013528","journal-title":"Acta Neuropathol"},{"issue":"4","key":"8668_CR18","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1212\/WNL.47.4.988","volume":"47","author":"MK Herrick","year":"1996","unstructured":"Herrick MK et al (1996) Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene. Neurology 47(4):988\u2013992","journal-title":"Neurology"},{"issue":"2","key":"8668_CR19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/jnnp-2014-308107","volume":"86","author":"LF Maia","year":"2015","unstructured":"Maia LF et al (2015) CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings. J Neurol Neurosurg Psychiatry 86(2):159\u2013167","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8668_CR20","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1212\/WNL.0000000000003001","volume":"87","author":"Y Sekijima","year":"2016","unstructured":"Sekijima Y et al (2016) Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis. Neurology 87:773\u2013781","journal-title":"Neurology"},{"issue":"8","key":"8668_CR21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","volume":"79","author":"T Coelho","year":"2012","unstructured":"Coelho T et al (2012) Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology 79(8):785\u2013792","journal-title":"Neurology"},{"issue":"8853","key":"8668_CR22","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0140-6736(93)93127-M","volume":"341","author":"G Holmgren","year":"1993","unstructured":"Holmgren G et al (1993) Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341(8853):1113\u20131116","journal-title":"Lancet"},{"issue":"2","key":"8668_CR23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ajmg.1320270213","volume":"27","author":"J Sequeiros","year":"1987","unstructured":"Sequeiros J, Saraiva MJ (1987) Onset in the seventh decade and lack of symptoms in heterozygotes for the TTRMet30 mutation in hereditary amyloid neuropathy-type I (Portuguese, Andrade). Am J Med Genet 27(2):345\u2013357","journal-title":"Am J Med Genet"},{"issue":"2\u20133","key":"8668_CR24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jmb.2011.12.060","volume":"421","author":"SM Johnson","year":"2012","unstructured":"Johnson SM et al (2012) The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug. J Mol Biol 421(2\u20133):185\u2013203","journal-title":"J Mol Biol"},{"issue":"5","key":"8668_CR25","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1210\/endo.133.5.8404661","volume":"133","author":"BR Southwell","year":"1993","unstructured":"Southwell BR et al (1993) Thyroxine transport to the brain: role of protein synthesis by the choroid plexus. Endocrinology 133(5):2116\u20132126","journal-title":"Endocrinology"},{"key":"8668_CR26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.nu.14.070194.002431","volume":"14","author":"Y Ingenbleek","year":"1994","unstructured":"Ingenbleek Y, Young V (1994) Transthyretin (prealbumin) in health and disease: nutritional implications. Annu Rev Nutr 14:495\u2013533","journal-title":"Annu Rev Nutr"},{"issue":"7","key":"8668_CR27","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1073\/pnas.0712197105","volume":"105","author":"JN Buxbaum","year":"2008","unstructured":"Buxbaum JN et al (2008) Transthyretin protects Alzheimer\u2019s mice from the behavioral and biochemical effects of Abeta toxicity. Proc Natl Acad Sci USA 105(7):2681\u20132686","journal-title":"Proc Natl Acad Sci USA"},{"issue":"35","key":"8668_CR28","doi-asserted-by":"crossref","first-page":"7707","DOI":"10.1523\/JNEUROSCI.2211-04.2004","volume":"24","author":"TD Stein","year":"2004","unstructured":"Stein TD et al (2004) Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis. J Neurosci 24(35):7707\u20137717","journal-title":"J Neurosci"},{"key":"8668_CR29","doi-asserted-by":"crossref","first-page":"20164","DOI":"10.1038\/srep20164","volume":"6","author":"M Alemi","year":"2016","unstructured":"Alemi M et al (2016) Transthyretin participates in beta-amyloid transport from the brain to the liver-involvement of the low-density lipoprotein receptor-related protein 1? Sci Rep 6:20164","journal-title":"Sci Rep"},{"issue":"2","key":"8668_CR30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/jnnp-2011-301308","volume":"83","author":"A Charidimou","year":"2012","unstructured":"Charidimou A, Gang Q, Werring DJ (2012) Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry 83(2):124\u2013137","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"22","key":"8668_CR31","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1212\/WNL.0000000000002175","volume":"85","author":"PA Boyle","year":"2015","unstructured":"Boyle PA et al (2015) Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology 85(22):1930\u20131936","journal-title":"Neurology"},{"issue":"5","key":"8668_CR32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000368998","volume":"38","author":"IB Meier","year":"2014","unstructured":"Meier IB et al (2014) Lobar microbleeds are associated with a decline in executive functioning in older adults. Cerebrovasc Dis 38(5):377\u2013383","journal-title":"Cerebrovasc Dis"},{"issue":"21","key":"8668_CR33","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","volume":"66","author":"MA Gertz","year":"2015","unstructured":"Gertz MA et al (2015) Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol 66(21):2451\u20132466","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"8668_CR34","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1073\/pnas.87.7.2843","volume":"87","author":"P Westermark","year":"1990","unstructured":"Westermark P et al (1990) Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 87(7):2843\u20132845","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"8668_CR35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/13506120410001673884","volume":"11","author":"L Lobato","year":"2004","unstructured":"Lobato L et al (2004) End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors. Amyloid 11(1):27\u201337","journal-title":"Amyloid"},{"issue":"6","key":"8668_CR36","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1399-0004.1991.tb03117.x","volume":"40","author":"O Sandgren","year":"1991","unstructured":"Sandgren O et al (1991) Vitreous involvement in familial amyloidotic neuropathy: a genealogical and genetic study. Clin Genet 40(6):452\u2013460","journal-title":"Clin Genet"},{"issue":"2","key":"8668_CR37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00109-010-0695-1","volume":"89","author":"E Ihse","year":"2011","unstructured":"Ihse E et al (2011) Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis. J Mol Med (Berl) 89(2):171\u2013180","journal-title":"J Mol Med (Berl)"},{"issue":"2","key":"8668_CR38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/path.1759","volume":"206","author":"J Bergstrom","year":"2005","unstructured":"Bergstrom J et al (2005) Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology. J Pathol 206(2):224\u2013232","journal-title":"J Pathol"},{"issue":"35","key":"8668_CR39","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1523\/JNEUROSCI.2417-11.2011","volume":"31","author":"X Li","year":"2011","unstructured":"Li X et al (2011) Neuronal production of transthyretin in human and murine Alzheimer\u2019s disease: is it protective? J Neurosci 31(35):12483\u201312490","journal-title":"J Neurosci"},{"issue":"21","key":"8668_CR40","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1523\/JNEUROSCI.4936-13.2014","volume":"34","author":"X Wang","year":"2014","unstructured":"Wang X et al (2014) The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer\u2019s disease model mice. J Neurosci 34(21):7253\u20137265","journal-title":"J Neurosci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-017-8668-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8668-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8668-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,10]],"date-time":"2018-02-10T09:32:30Z","timestamp":1518255150000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-017-8668-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,5]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["8668"],"URL":"https:\/\/doi.org\/10.1007\/s00415-017-8668-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,5]]}}}